Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis

Fig. 3

Percentages of stromal and tumoral cells and their categorization as high or low expression according to ROC cutoff points. A: MMP-2. High expression in stromal cells (91.0%) and tumor cells (89.7%); B: MMP-2. Low expression in stromal cells (46.7%) and tumor cells (36.4%); C: MMP-14. High expression in stromal cells (97.1%) and tumor cells (85.5%), D: MMP-14. Low expression in stromal cells (12.1%) and tumor cells (20.4%)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us